Your fight against classical
Hodgkin lymphoma may
continue here
OPDIVO is an FDA-approved immunotherapy option for previously treated classical Hodgkin lymphoma
Your fight against classical
Hodgkin lymphoma may
continue here
OPDIVO is an FDA-approved immunotherapy option for previously treated classical Hodgkin lymphoma
Actor portrayals.
OPDIVO is a treatment option for certain adults with previously treated classical Hodgkin lymphoma whose cancer has come back or spread
OPDIVO will not work for everyone. Individual results may vary.